Dexcom Projects 2026 Revenue Between $5.20B-$5.25B and Authorizes $1B Share Buyback
Dexcom (DXCM) reported an 11% year-over-year revenue increase for the third quarter of 2025 compared to the same period in 2024. CEO Jacob Leach highlighted that the company successfully gained market share during the quarter, driven by strong revenue growth within the United States market. Looking ahead, management provided optimistic long-term guidance, projecting annual revenue for 2026 to fall between $5.20 billion and $5.25 billion. To support shareholder value, the company has also authorized an additional $1 billion share repurchase program.
Tickers: $DXCM